Despite advancements in the public's understanding of HIV infection, felt stigma towards individuals living with HIV persists. Stigma has been associated with adverse health outcomes, including poor adherence to care, and increased participation in HIV transmission risk behaviours. We evaluated the level of felt stigma and its relationship to other psychosocial and medical factors among a sample of 201 individuals with HIV engaged in care. The overall mean stigma score, as measured by the Reece Stigma Scale, was 21.7 (SD 8.7). In univariate analysis, felt stigma scores were higher among women, African Americans, younger participants, and individuals with less education. Higher felt stigma scores were also found among individuals who reported having fair to poor overall health, moderate to severe symptoms of depression and anxiety, and those with a current diagnosis of alcohol dependence, generalised anxiety disorder, agoraphobia, pain disorder, and current smokers. Higher felt stigma scores were independently associated with individuals with anxiety symptoms. These analyses highlight that stigma persists among individuals with HIV and may play an important role in HIV care. The relationship between psychiatric disorders and psychosocial factors highlights an opportunity to develop interventions that will address these common comorbidities and reduce stigma.
Introduction
Despite significant advances in HIV care, HIV-related stigma remains a problematic component of effective disease management. 1 Societal perceptions and biases about HIV infection persist and result in stigma that contribute to psychological distress and directly affects health outcomes and risk behaviours. [2] [3] [4] [5] [6] [7] [8] [9] The reaction of communities to HIV infection has created both internalised and externalised stigma primarily related to the behaviours associated with a higher risk of HIV acquisition and the characteristics of certain groups that have historically been most affected by the disease (e.g. men who have sex with men and injection drug users). 10 Stigma has been identified as a barrier to HIV testing and engagement into care; as such, addressing stigma is an integral component of HIV prevention efforts. 8 Although stigma is a contributing factor to psychological distress, it is unclear if and how it relates to psychiatric disorders, which often complicate HIV management. 11, 12 This study aims to examine the intersection of mental health and felt stigma.
Applied to a number of health and social issues, stigma is often difficult to quantify. Early descriptions of stigma emphasise its relation to the deviation of individuals from social norms, resulting in cognitive affirmations of unworthiness. [13] [14] [15] [16] The modern definition of stigma expands on this interpretation to include enacted stigma, or outward expressions of discrimination and rejection from community members, and felt stigma, or the perception of others' discrediting thoughts, feelings, and behaviours. 8, 9 Broadly, HIVrelated stigma includes feelings of social isolation and rejection, and has an adverse impact on engagement in medical care and self-care behaviours in certain cultural contexts. 8, 9, 17, 18 Amplifying feelings of social anxiety, these perceptions also negatively influence serostatus disclosure patterns while increasing engagement in HIV transmission risk behaviours. 19 Defining HIV-related felt stigma is challenging given that diverse communities express and experience it differently. As HIV infection has transitioned from a uniformly fatal illness to a manageable chronic disease among individuals who have access and adhere to medical care, fewer studies of felt stigma have been conducted in the US compared to earlier years of the epidemic. While the research has not continued as fruitfully, the goal of reducing HIV-related discrimination is included in the National HIV/AIDS Strategy. 20 Recent studies have been conducted in developing regions of the world and have identified lack of knowledge and the fear associated with HIV infection as two factors contributing to increased HIV-related felt stigma on the community level, 19 ,21 yet over time developing regions are likely to need to focus their work on reducing felt stigma and HIV-related discrimination as well. 22 Unfortunately, in the US, the advancement of HIV medical care may cause providers and researchers to assume that stigma has effectively disappeared.
This study was conducted to examine HIV-related felt stigma as experienced by a cohort of individuals with HIV engaged in medical care at a Midwestern US outpatient clinic. Using a measure that focuses on individual perceptions of felt stigma, 15, 16 the current study aimed to identify the prevalence of felt stigma among this population and its association with psychiatric disorders and HIV-related health outcomes in the era of combination antiretroviral therapy (cART).
Methods
Individuals with HIV, 18 years of age or older, presenting for care at the Washington University HIV Clinic were eligible to participate in a 2-hour interview during 2009. Individuals were recruited during their regularly scheduled clinic visits; if they expressed interest in participating in any study they shared their telephone number. Project staff would then call potential participants to inform them of the opportunity, gauge interest, and send informed consent forms for their review prior to their scheduled interview date. Of those who agreed to participate, 72% presented to and completed the interview. Individuals were remunerated for participation in the study and received transportation vouchers, when necessary. Each interview was computerised, yet interviewers were utilised to read each question and enter participants' responses. The interviewers were trained to conduct the interviews in a manner that increases the validity of the responses, as done with the DIS. 23 Interviews were conducted in a private room and all study materials were approved by the Washington University Human Protection Office. All participants provided written informed consent before participation.
HIV-related felt stigma was measured using the Reece Stigma Scale, a 9-item instrument. 24 Each item asks participant to recall if they had felt stigma related to the item within the past 30 days, ranging from never (1) to always (5) . The total possible scores ranging from 9 (no perceived stigma) to 45 (high perceived stigma). The scale has been applied previously in a southeastern US urban clinic setting, as well as in sub-Saharan Africa. [24] [25] [26] Widely accepted for conducting diagnostic interviews both in practice and for research purposes, the Diagnostic Interview Schedule was utilised to determine current psychiatric diagnoses (within the past 12 months) through structured computerised interviews with trained 'lay persons'. 23 These diagnostic interviews identified current (within 12 months) psychiatric disorders. Additional results of these interviews are described elsewhere. 27 Symptoms of depression were assessed using the Patient Health Questionnaire-9 (PHQ-9) 28 and overall health was measured with the Short-Form 12 (SF-12), 29 as has been used previously in populations with HIV. 30 We used the sum score of the PHQ-9 (range 0-27) to identify mild (5-9), moderate (10) (11) (12) (13) (14) , and severe (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) depressive symptoms, as the scale developers suggest. 31 The reliability of the PHQ-9 in this study population was a ¼ 0.89. The analyses were only conducted on the first question of the overall health measure, SF-12, 'Would you say that in general your health is: excellent, very good, good, fair, or poor?' For the analyses, we dichotomised the response options: excellent-good and fairpoor, as commonly done. 32, 33 Sexual orientation was calculated by self-reports of sex partner gender only among those who reported being sexually active within the previous 4 months. Additional data by selfreports were included: condom at last sexual encounter, 34, 35 illicit drug use in the last 30 days, and amount of alcohol consumed in the previous 7 days (among those who had reported consuming within that time frame).
Data were abstracted from participants' medical records to ascertain the most recent CD4 cell counts, HIV viral loads, and length of time since HIV diagnosis (in years). Combination antiretroviral therapy (cART) was defined as the use of 3 antiretroviral drugs.
Variables were dichotomised as follows: HIV viral loads (<400 copies/mL and 400 copies/mL); education level (high school graduate/GED or >high school degree); employment status (unemployed, including those receiving disability benefits, and employed, part-or full-time); annual income ( and >$10,000); depression severity (those who expressed symptoms of major or other depressive disorders (MDD/ODD) within the past 2 weeks and those who did not); DIS diagnoses were identified when the appropriate number of symptoms were endorsed; and stigma was a continuous variable.
Statistical analyses
Descriptive analyses were utilised to assess the sample. A principal component analysis was conducted using a varimax rotation to assess a one-factor solution for the Reece Stigma Scale, which resulted in 50.5% of the variability to be explained by one factor. Reliability of the scale was assessed using Cronbach's alpha (a ¼ 0.87). Univariate analyses were conducted to assess relationships between socio-demographic and psychological characteristics and mean stigma scores. Linear regression models were created to evaluate independent relationships between stigma scores and sociodemographic and psychiatric determinants using a backward stepwise approach. These models included variables which were associated with higher stigma scores in univariate analyses (p < 0.10). All tests were 2-tailed with p < 0.05 considered to be significant. Data analyses were performed using SPSS software (version 21.0, Chicago, IL).
Results
A sample of 201 individuals with HIV infection completed the interviews; 69% men, 72% African American, 63% unemployed, with a mean age of 43 years. Overall, 83% of individuals were receiving cART and 78% achieved virologic suppression on the most recent evaluation. The most prevalent current psychiatric disorders were Pain Disorder (42%), Major Depressive Episode (38%), Generalised Anxiety Disorder (14%), and Alcohol Dependence (17%). Additional demographic characteristics are included in Table 1 .
The mean total of the Reece Stigma Scale was 21.7 (SD ¼ 8.7; range 9-45). Among the nine items, the most prominently endorsed symptoms included that individuals felt that keeping their HIV status as secret was important, they avoided dating because most people did not want to date someone who had HIV, and avoided situations because they were worried about people knowing they had HIV. Table 2 includes a summary of each item and the frequency of responses, as well as the results of the principal component analysis.
In univariate analyses, elevated felt stigma scores were more prevalent among women, those with less education, and African Americans (p < 0.05 for all). Individuals who reported having poor to fair overall health had higher felt stigma scores than those reporting excellent to good health, as well as current smokers (p < 0.05 for both). Higher felt stigma scores were associated with reporting moderate-severe symptoms of depression and anxiety, being diagnosed with current generalised anxiety disorder (GAD), agoraphobia, alcohol dependence, and pain disorder (p < 0.05 for all). We identified no significant differences in felt stigma scores by HIV viral loads, CD4 cell counts, or health risk behaviours (including multiple current sexual partners, unprotected sex at last sexual encounter, and current alcohol or illicit drug use).
In linear regression analyses, we controlled for significant associations (0.10), individuals who expressed moderate to severe symptoms of anxiety (3.39 [95%CI: 0.10, 0.37]) were more likely to express higher felt stigma scores. We identified significant associations of higher felt stigma scores among heterosexual participants than homosexual partners (detailed in the Table) . This finding was only among those who were sexually active in the previous 4 months. These results are detailed in Table 3 .
Discussion
Stigma remains an important aspect of HIV disease management, even among individuals engaged in medical care. We identified patterns of increased felt stigma reported among those with less education, African Americans, individuals who rated their general health worse, and current smokers. Additionally, higher levels of felt stigma was associated among individuals who also endorse moderate to severe symptoms of depression and anxiety; as well as a current diagnosis of GAD, agoraphobia, alcohol dependence, and pain disorder. Felt stigma was independently associated with individuals who were heterosexual and those endorsing moderate to severe anxiety symptoms. These findings suggest that felt stigma not only persists among populations with HIV in the US but also has a complex relationship with social and behavioural factors as well as mental health comorbidities.
Populations with HIV have higher smoking rates than uninfected populations; they may be using smoking as a coping strategy. 36, 37 Current smokers more often reported higher rates of stigma. As higher rates of felt stigma were also more common among individuals with current alcohol dependence, this suggests another maladaptive coping strategy, as individuals may self-medicate with alcohol and other substances. Additionally, depression, anxiety, and a lower perceived general overall health were associated with higher rates of felt stigma, similar to previous findings that identified an association between poor perceived health and more severe depressive symptoms to poorer medication adherence among individuals engaged in HIV care. 2 Importantly, future studies need to assess the directionality of these relationships with felt stigma in order to better address overall wellness. Managing HIV is complex; thus, identifying healthy coping strategies in order to address chronic disease risk behaviours would enhance health outcomes that need to be addressed in clinic-and communitybased interventions.
Independently, our study identified that heterosexual individuals had significantly increased risk of experiencing HIV-related felt stigma. This difference has important implications. Historically, stigma was highest among communities of men who have sex with men or gay men. We measured sexual orientation among individuals who had reported having sex within the past 4 months, which provided a more accurate sexual history. Yet, it did not allow our felt stigma analyses to capture those who were not sexually active by their orientation. This finding highlights higher felt stigma may be increasing transmission risk, since higher felt stigma is associated with less serostatus disclosure and condom use. 38, 39 Additionally, we (continued) identified that endorsing moderate to severe anxiety symptoms was associated with the risk of felt stigma. These findings are important to highlight and suggest that anxiety symptoms are in some ways easier to intervene on rather than a diagnosed psychiatric disorder or felt stigma. This clinic-based sample suggests that while individuals are engaged in care, they may still be struggling to consistently engage in care due to felt stigma, psychiatric disorders and psychological distress, and other life complexities. Current trends in intervention development stress the importance of addressing felt stigma among populations with HIV. Given the variability in cultural and community norms, interventions will likely require tailoring for populations of interest. Specifically, identifying patterns of psychological distress or psychiatric disorders that are often related to higher felt stigma will be beneficial for providers to guide needed interventions.
While we were unable to detect significant associations between felt stigma scores, engagement in risk behaviours, and HIV outcomes, selection bias may have contributed to these results. Also, individuals may be managing their felt stigma by avoidance, which is a characteristic of anxiety and depressive symptoms. Given that our sample was actively engaged in HIV care at the time of recruitment, we recognise a selection bias as we were not able to fully explore the impact of felt stigma on individuals who may be experiencing higher levels of felt stigma who are not in care and having a more significant impact on their HIVrelated health outcomes. Furthermore, we are unable to describe the directionality of these findings, due to the cross-sectional research design. Additionally, we defined sexual orientation only among individuals who endorsed being sexually active within the previous 4 months. Additionally, our sample size was limited by the depth of the interviews. While the psychiatric diagnoses identified through the interviews were based on valid and reliable measures, these reports do no substitute for clinical diagnoses. Despite these limitations, this study suggests relationships of stigma and mental health issues that may help develop interventions that may address individual-level felt stigma.
